“…Although the vast majority of adults are seropositive for JCV, the virus, at low infection levels in kidney epithelial tissue and bone marrow, rarely causes any symptoms. Under certain immunosuppressive conditions, however, JCV undergoes genetic changes in its non-coding replication/transcription control region and gains the ability to infect oligodendrocytes in the brain (Johnson et al, 2015). In this case Pura acts by altering both gene expression (Chen et al, 1995; Krachmarov et al, 1996; Gallia et al, 1998; White et al, 2009; Sariyer et al, 2016) and replication of JCV (Chen et al, 1995; Krachmarov et al, 1996; Wortman et al, 2000; Daniel et al, 2001; Reiss and Khalili, 2003; Daniel et al, 2004).…”